Low-Dose Aspirin and Pancreatic Cancer Risk—Letter

Cancer Epidemiology Biomarkers and Prevention - United States
doi 10.1158/1055-9965.epi-17-0115
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Clopidogrel and Low-Dose Aspirin, Alone or Together, Reduce Risk of Colorectal Cancer

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2019English

Low-Dose Aspirin Use and Cancer Characteristics: A Population-Based Cohort Study

British Journal of Cancer
Cancer ResearchOncology
2013English

Points: A Regimen of Low Dose Aspirin

BMJ
1983English

Low-Dose Aspirin Use and Survival in Breast Cancer Patients: A Nationwide Cohort Study

Cancer Epidemiology
Cancer ResearchEpidemiologyOncology
2017English

Low-Dose Aspirin Use and Survival in Breast Cancer Patients: A Nationwide Cohort Study

Cancer Epidemiology
Cancer ResearchEpidemiologyOncology
2017English

Gastrointestinal Symptoms in Low-Dose Aspirin Users: A Comparison Between Plain and Buffered Aspirin

Netherlands Heart Journal
Cardiovascular MedicineCardiology
2014English

Aspirin and Nonsteroidal Anti-Inflammatory Drug Use and Risk of Pancreatic Cancer: A Meta-Analysis

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2006English

952: Low-Dose Aspirin (ASA) for Preeclampsia Prevention Among High-Risk Women by Ethnicity and Race

American Journal of Obstetrics and Gynecology
GynecologyObstetrics
2018English

Editorial: Lower Gastrointestinal Bleeding and Low-Dose Aspirin-Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy